- Previous Close
38.63 - Open
38.02 - Bid --
- Ask --
- Day's Range
38.00 - 38.65 - 52 Week Range
37.81 - 42.86 - Volume
81,569 - Avg. Volume
30,301 - Market Cap (intraday)
521.384M - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
9.76 - EPS (TTM)
3.93 - Earnings Date --
- Forward Dividend & Yield 2.56 (6.66%)
- Ex-Dividend Date Nov 15, 2024
- 1y Target Est
--
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BME
View More
Performance Overview: BME
Trailing total returns as of 11/19/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BME
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BME
View MoreValuation Measures
Market Cap
521.38M
Enterprise Value
--
Trailing P/E
9.76
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.71
Price/Book (mrq)
0.85
Enterprise Value/Revenue
9.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
683.94%
Return on Assets (ttm)
0.17%
Return on Equity (ttm)
9.01%
Revenue (ttm)
7.99M
Net Income Avi to Common (ttm)
54.65M
Diluted EPS (ttm)
3.93
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14k
Total Debt/Equity (mrq)
0.17%
Levered Free Cash Flow (ttm)
1.69M
Company Insights: BME
BME does not have Company Insights